NervGen Pharma Corp. ("NervGen" or the "Company") (TSXV: NGEN) (NASDAQ: NGEN), a clinical-stage biopharmaceutical company developing first-in-class ...
For immediate concerns about closed captioning of broadcast programs or online video content during weekday business hours 8 a.m.-5 p.m., call David Harpe at (303) 830-6426 or e-mail ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results